SlideShare une entreprise Scribd logo
1  sur  44
Télécharger pour lire hors ligne
Amer Ali Khaleel
M.SC in Medical Immunology
Hawler Medical University
Antimicrobial Resistance
(AMR)
2
Antimicrobial Resistance
 Antimicrobial resistance (AMR) is one of the
most serious public health threats of the
twenty-first century .
 Resistance to antimicrobial agents has
become a major source of morbidity and
mortality worldwide.
Nearly 700,000 people around the
world die every year due to drug-
resistant infections.
3
Antimicrobial agents
 Antimicrobial agents can be divided into groups based on the
mechanism of antimicrobial activity.
1. Agents that inhibit cell wall synthesis.
2. Depolarize the cell membrane.
3. Inhibit protein synthesis.
4. Inhibit nuclei acid synthesis.
5. Inhibit metabolic pathways in bacteria.
4
5
Antimicrobial
Resistance
 Most pathogenic microorganisms have the
capability of developing resistance to at least
some antimicrobial agents.
Factors contributing to Antibiotic Resistance
1- Environmental Factors.
2- Drug Related Factors.
3- Patient Related Factors.
4- Physician Related Factors.
6
1. Environmental Factors
1. Huge populations and overcrowding
2. Rapid spread – increased travelling
3. Poor sanitation
4. Increases community acquired resistance
5. Ineffective infection control program
6. Increasing national and international travel.
7. Widespread use of antibiotics in animal husbandry and
agriculture and as medicated cleansing products.
7
2- Drug Related Factors
1. Fake drugs.
2. Quality of the drug.
3. Soaring use of antibiotics.
4. Over the counter availability of antimicrobials.
5. Irrational fixed dose combination of antimicrobials
6. Counterfeit and substandard drug causing sub-optimal
blood concentration
8
3. Patient Related Factors
1. Poor adherence of dosage Regimens
2. Poverty .
3. Lack of sanitation concept.
4. Lack of education.
5. Self-medication.
6. Misconception.
9
4-Physician / Prescriber Related Factors
1. Inappropriate use of available drugs.
2. Increased empiric poly-antimicrobial use.
3. Overuse of antimicrobials.
4. Inadequate dosing.
5. Lack of current knowledge and training.
10
So also just remember , there is natural
resistances of bacteria against antibiotics
, so it is not fault on these four factors.
11
12
Bacteriostatic vs. Bacteriocidal
 Static antibiotics include: Chloramphenicol,
Macrolides, Clindamycin, Sulfa, Trimethoprim,
Tetracyclines
 Cidal antibiotics include: Aminoglycosides, Beta-
lactams, Vancomycin, Quinolones, Rifampin, and
Metronidazole.
13
ANTIMICROBIAL RESISTANCE
Antimicrobial resistance can be of two
types, intrin-sic and acquired.
14
15
 Intrinsic or natural (always expressed in the species),
It is the innate ability of a bacterium to resist a class
of antibiotics.
 The most common bacterial mechanisms involved
in intrinsic resistance are reduced permeability of
the outer membrane (LPS) and the natural activity
of efflux pumps.
16
b) Acquired resistance whereby a naturally susceptible
microorganism acquires ways of not being affected by
the drug.
 Bacteria acquire any genetic material: transformation,
transposition, and conjugation (all termed horizontal
gene transfer-HGT), plus, the bacteria may experience
mutations to its own chromosomal DNA.
17
Non-genetics
Mechanism of Antimicrobial Resistance
 Bacteria develop antimicrobial resistance by several
mechanisms.
1. Limiting uptake of a drug. (natural)
2. Modification of a drug target.
3. Inactivation of a drug.
4. Active efflux of a drug.
18
Mechanism of Antimicrobial Resistance
 Because of differences in structure, there is variation in the
types of mechanisms used by Gram negative bacteria versus
Gram positive bacteria.
 Gram negative bacteria make use of all four main
mechanisms, whereas Gram positive bacteria less
commonly use limiting the uptake of a drug (don't have an
LPS outer membrane), and don't have the capacity for
certain types of drug efflux mechanisms.
19
20
1
2
4
3
1. Limiting uptake of a drug.
 There is a natural difference in the ability of bacteria
to limit the uptake of antimicrobial agents.
 The structure and functions of the LPS layer in G-
bacteria provides a barrier to certain types of
molecules.
21
 Certain bacteria modify their cell membrane porin
channels; thereby preventing the antimicrobials from
entering into the cell. (genetics)
 There are two main ways in which porin changes can
limit drug uptake: a decrease in the number of porins
present, and mutations that change the selectivity of
the porin channel.
22
 This strategy has been observed in many Gram-
bacteria such as Pseudomonas, Enterobacter and
Klebsiella species against drugs such as imipenem,
aminoglycosides and quinolones.
23
 Gram positive bacteria, Staphylococcus aureus,
recently has developed resistance to vancomycin. Of the
two mechanisms that S. aureus uses against vancomycin.
 S. aureus produce a thickened cell wall which makes it
difficult for the drug to enter the cell and Provides an
intermediate resistance to vancomycin. These strains are
designated as VISA strains. (non-genetic)
24
2. Modification of a drug target.
 There are multiple components in the bacterial
cell that may be targets of antimicrobial agents
and there are just as many targets that may be
modified by the bacteria to enable resistance to
those drugs. (genetic)
25
 One mechanism of resistance to the β-lactam drugs
used almost exclusively by G+ bacteria is via
alterations in the structure and/or number of PBPs
(penicillin-binding proteins).
 PBPs are transpeptidases involved in the
construction of peptidoglycan in the cell wall.
26
 A change in the number (increase in PBPs that have
a decrease in drug binding ability, or decrease in
PBPs with normal drug binding) of PBPs impacts the
amount of drug that can bind to that target.
27
 A change in structure (e.g. PBP2a in S. aureus by
acquisition of the mecA gene) may decrease the ability of
the drug to bind, or totally inhibit drug binding.
28
Antibiotic
 The glycopeptides (e.g. vancomycin) also work by
inhibiting cell wall synthesis and lipopeptides (e.g.
daptomycin) work by depolarizing the cell membrane.
 Resistance to vancomycin has become a major issue in
the enterococci (VRE—vancomycin-resistant
enterococci) and in Staphylococcus aureus (MRSA-
Methicillin-resistant Staphylococcus aureus).
29
 Resistance is mediated through acquisition of van genes
which results in changes in the structure of peptidoglycan
precursors that cause a decrease in the binding ability of
vancomycin.
 Daptomycin requires the presence of calcium for binding.
Mutations in genes (e.g. mprF) change the charge of the
cell membrane surface to positive, inhibiting the binding of
calcium, and therefore, daptomycin.
30
 Resistance to drugs that target the ribosomal subunits
may occur via ribosomal mutation (aminoglycosides)
,ribosomal subunit methylation most commonly
involving erm genes, or ribosomal protection
(tetracyclines).
 These mechanisms interfere with the ability of the
drug to bind to the ribosome.
31
 Selective toxicity (antibiotics) , the only affect the
bacterium not human, due to affect the specific
genes that only bacteria.
32
 For drugs that target nucleic acid synthesis
(fluoroquinolones), resistance is via modifications in
DNA gyrase (G- bacteria e.g. gyrA) or topoisomerase
IV (G + bacteria e.g. grlA).
 These mutations cause changes in the structure of
gyrase and topoisomerase which decrease or
eliminate the ability of the drug to bind to these
components.
33
 There are two main ways in which bacteria inactivate
drugs; by
1-Actual degradation of the drug, or by
2-Transfer of a chemical group to the drug.
34
3. Inactivation of a drug.
 1-Actual degradation of the drug, or by
The β-lactamases are a very large group of drug
hydrolyzing enzymes .Another drug that can be
inactivated by hydrolyzation is tetracycline, via
the tetX gene.
35
 2-Transfer of a chemical group to the drug.
Drug inactivation by transfer of a chemical group to the
drug most commonly uses transfer of acetyl group.
 There are a large number of transferases that have
been identified. Acetylation is the most diversely used
mechanism, and is known to be used against the
aminoglycosides.
36
 Bacteria possess chromosomally encoded genes for efflux
pumps. Some are expressed constitutively, and others are
induced or overexpressed (high-level resistance is usually via
a mutation that modifies the transport channel) under certain
environmental stimuli or when a suitable substrate is present.
 The efflux pumps function primarily to rid the bacterial cell of
toxic substances, and many of these pumps will transport a
large variety of compounds (multi-drug [MDR] efflux pumps).
37
4. Active efflux of a drug.
 Most bacteria possess many different types of efflux pumps.
 There are five main families of efflux pumps in bacteria
classified based on structure and energy source:
1-The ATP-binding cassette (ABC) family,
2-The multidrug and toxic compound extrusion (MATE) family,
3-The small multidrug resistance (SMR) family,
4-The major facilitator superfamily (MFS), and
5-The resistance-nodulation-cell division (RND) family.
38
 Efflux pumps found in G + bacteria may confer intrinsic
resistance because of being encoded on the chromosome
(natural).
 There are also G + efflux pumps known to be carried on plasmids
(aquarid).
 These pumps include members of the MATE and MFS families.
 Efflux pumps found in G -bacteria are widely distributed and may
come from all five of the families, with the most clinically
significant pumps belonging to the RND family. 39
40
Figure: General structure of main efflux pump families.
What is the difference between antibiotic
and antimicrobial resistance?
 Antibiotics are medicines used to prevent and treat bacterial
infections. Antibiotic resistance occurs when bacteria change in
response to the use of these medicines. Bacteria, not humans,
become antibiotic resistant. These bacteria may then infect
humans and are harder to treat than non-resistant bacteria.
 Antimicrobial resistance is a broader term, encompassing
resistance to drugs to treat infections caused by other microbes
as well, such as parasites (e.g. malaria), viruses (e.g. HIV) and
fungi (e.g. Candida).
41
42
43
Summary
References
 An overview of the antimicrobial resistance mechanisms of
bacteria ,2018, doi: 10.3934/microbiol.2018.3.482.
 A Review on Antibiotic Resistance: Alarm Bells are
Ringing,2017, doi: 10.7759/cureus.1403
 WHO,2018
 CDC,2018
44

Contenu connexe

Tendances

Tendances (20)

Antibiotic Mechanisms of Action
Antibiotic Mechanisms of ActionAntibiotic Mechanisms of Action
Antibiotic Mechanisms of Action
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Antimicrobial resistance
Antimicrobial resistanceAntimicrobial resistance
Antimicrobial resistance
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Drug Resistance Mechanism
Drug Resistance Mechanism Drug Resistance Mechanism
Drug Resistance Mechanism
 
Antibiotic stewardship program
Antibiotic stewardship programAntibiotic stewardship program
Antibiotic stewardship program
 
Chapter 6 antimicrobial drugs
Chapter 6   antimicrobial drugsChapter 6   antimicrobial drugs
Chapter 6 antimicrobial drugs
 
Antimicrobial resistance mechanism
Antimicrobial resistance mechanismAntimicrobial resistance mechanism
Antimicrobial resistance mechanism
 
Principles of antimicrobial
Principles of antimicrobialPrinciples of antimicrobial
Principles of antimicrobial
 
Antibacterial agents
Antibacterial agentsAntibacterial agents
Antibacterial agents
 
Antibiotic types and mechanism of action
Antibiotic types and mechanism of actionAntibiotic types and mechanism of action
Antibiotic types and mechanism of action
 
1. INTRODUCTION OF CHEMOTHERAPY
1. INTRODUCTION OF CHEMOTHERAPY1. INTRODUCTION OF CHEMOTHERAPY
1. INTRODUCTION OF CHEMOTHERAPY
 
Antimicrobial stewardship
Antimicrobial stewardshipAntimicrobial stewardship
Antimicrobial stewardship
 
3. ANTIBIOTIC (PROTEIN SYNTHESIS INHIBITORS)
3. ANTIBIOTIC (PROTEIN SYNTHESIS INHIBITORS)3. ANTIBIOTIC (PROTEIN SYNTHESIS INHIBITORS)
3. ANTIBIOTIC (PROTEIN SYNTHESIS INHIBITORS)
 
Sulphonamides and Quinolones
Sulphonamides and QuinolonesSulphonamides and Quinolones
Sulphonamides and Quinolones
 
Antimicrobial therapy-General consideration
Antimicrobial therapy-General considerationAntimicrobial therapy-General consideration
Antimicrobial therapy-General consideration
 
Antibiotic resistance dr sachin
Antibiotic resistance dr sachinAntibiotic resistance dr sachin
Antibiotic resistance dr sachin
 
Anti-Fungal drugs
Anti-Fungal drugsAnti-Fungal drugs
Anti-Fungal drugs
 
Generations of antibiotics
Generations of antibioticsGenerations of antibiotics
Generations of antibiotics
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 

Similaire à Antimicrobial Resistance (AMR)

antibiotcresistance-191028163013 (1).pdf
antibiotcresistance-191028163013 (1).pdfantibiotcresistance-191028163013 (1).pdf
antibiotcresistance-191028163013 (1).pdfStephenNjoroge22
 
antibiotcresistance-191028163013.pptx
antibiotcresistance-191028163013.pptxantibiotcresistance-191028163013.pptx
antibiotcresistance-191028163013.pptxisratsadia
 
Antimicrobial Compounds.pdf
Antimicrobial Compounds.pdfAntimicrobial Compounds.pdf
Antimicrobial Compounds.pdfSamrahNadeem2
 
Antibiotic resistance A major source of morbidity and mortality worldwide.pptx
Antibiotic resistance A major source of morbidity and mortality worldwide.pptxAntibiotic resistance A major source of morbidity and mortality worldwide.pptx
Antibiotic resistance A major source of morbidity and mortality worldwide.pptxSmitha Vijayan
 
Bacterial drug resistance
Bacterial drug resistanceBacterial drug resistance
Bacterial drug resistanceLuxlakshmi1
 
Drug delivery strategies for combating multiple drug resistance
Drug delivery strategies for combating multiple drug resistanceDrug delivery strategies for combating multiple drug resistance
Drug delivery strategies for combating multiple drug resistancetanimittal
 
Development of Multiple Antibiotic Resistance in Microbes (Microbial Genetics)
Development of Multiple Antibiotic Resistance in Microbes (Microbial Genetics) Development of Multiple Antibiotic Resistance in Microbes (Microbial Genetics)
Development of Multiple Antibiotic Resistance in Microbes (Microbial Genetics) Zohaib HUSSAIN
 
Bacterial resistance mechanisms and new trends for resistance overcoming
Bacterial resistance mechanisms and new trends for resistance overcoming Bacterial resistance mechanisms and new trends for resistance overcoming
Bacterial resistance mechanisms and new trends for resistance overcoming Mohammed Fawzy
 
ANTIMICROBIAL DRUGS (Part 2)
ANTIMICROBIAL DRUGS (Part 2) ANTIMICROBIAL DRUGS (Part 2)
ANTIMICROBIAL DRUGS (Part 2) Surya Amal
 
Antimicrobial Agents and Antimicrobial Resistance.pptx
Antimicrobial Agents and Antimicrobial Resistance.pptxAntimicrobial Agents and Antimicrobial Resistance.pptx
Antimicrobial Agents and Antimicrobial Resistance.pptxDr. Rakesh Prasad Sah
 
Antimicrobial Drug Resist.
Antimicrobial Drug Resist.Antimicrobial Drug Resist.
Antimicrobial Drug Resist.mohammed sediq
 
Multi drug resistance molecular pathogenesis
Multi drug resistance   molecular pathogenesisMulti drug resistance   molecular pathogenesis
Multi drug resistance molecular pathogenesisAlagar Suresh
 
chemotherapy-181027041852-1.pdf
chemotherapy-181027041852-1.pdfchemotherapy-181027041852-1.pdf
chemotherapy-181027041852-1.pdfmousaderhem1
 
ESKAPE Pathogens.pptx
ESKAPE Pathogens.pptxESKAPE Pathogens.pptx
ESKAPE Pathogens.pptxMayuriRani3
 
Mechanism of development for drug resistance
Mechanism of development for drug resistanceMechanism of development for drug resistance
Mechanism of development for drug resistanceDr Nikita Ingale
 
Mechanism of antibiotic resistance
Mechanism of antibiotic resistanceMechanism of antibiotic resistance
Mechanism of antibiotic resistanceSuman Das
 
Antibiotics and other chemotherapeutic agents -Antimicrobial spectrum and mod...
Antibiotics and other chemotherapeutic agents -Antimicrobial spectrum and mod...Antibiotics and other chemotherapeutic agents -Antimicrobial spectrum and mod...
Antibiotics and other chemotherapeutic agents -Antimicrobial spectrum and mod...radhikapilli
 

Similaire à Antimicrobial Resistance (AMR) (20)

antibiotcresistance-191028163013 (1).pdf
antibiotcresistance-191028163013 (1).pdfantibiotcresistance-191028163013 (1).pdf
antibiotcresistance-191028163013 (1).pdf
 
antibiotcresistance-191028163013.pptx
antibiotcresistance-191028163013.pptxantibiotcresistance-191028163013.pptx
antibiotcresistance-191028163013.pptx
 
Antimicrobial Compounds.pdf
Antimicrobial Compounds.pdfAntimicrobial Compounds.pdf
Antimicrobial Compounds.pdf
 
Antibiotic resistance A major source of morbidity and mortality worldwide.pptx
Antibiotic resistance A major source of morbidity and mortality worldwide.pptxAntibiotic resistance A major source of morbidity and mortality worldwide.pptx
Antibiotic resistance A major source of morbidity and mortality worldwide.pptx
 
Bacterial drug resistance
Bacterial drug resistanceBacterial drug resistance
Bacterial drug resistance
 
Drug delivery strategies for combating multiple drug resistance
Drug delivery strategies for combating multiple drug resistanceDrug delivery strategies for combating multiple drug resistance
Drug delivery strategies for combating multiple drug resistance
 
Development of Multiple Antibiotic Resistance in Microbes (Microbial Genetics)
Development of Multiple Antibiotic Resistance in Microbes (Microbial Genetics) Development of Multiple Antibiotic Resistance in Microbes (Microbial Genetics)
Development of Multiple Antibiotic Resistance in Microbes (Microbial Genetics)
 
Bacterial resistance mechanisms and new trends for resistance overcoming
Bacterial resistance mechanisms and new trends for resistance overcoming Bacterial resistance mechanisms and new trends for resistance overcoming
Bacterial resistance mechanisms and new trends for resistance overcoming
 
ANTIMICROBIAL DRUGS (Part 2)
ANTIMICROBIAL DRUGS (Part 2) ANTIMICROBIAL DRUGS (Part 2)
ANTIMICROBIAL DRUGS (Part 2)
 
Antimicrobial Agents and Antimicrobial Resistance.pptx
Antimicrobial Agents and Antimicrobial Resistance.pptxAntimicrobial Agents and Antimicrobial Resistance.pptx
Antimicrobial Agents and Antimicrobial Resistance.pptx
 
Antibiotics resistance lecture
Antibiotics resistance lectureAntibiotics resistance lecture
Antibiotics resistance lecture
 
Antimicrobial Drug Resist.
Antimicrobial Drug Resist.Antimicrobial Drug Resist.
Antimicrobial Drug Resist.
 
Multi drug resistance molecular pathogenesis
Multi drug resistance   molecular pathogenesisMulti drug resistance   molecular pathogenesis
Multi drug resistance molecular pathogenesis
 
chemotherapy-181027041852-1.pdf
chemotherapy-181027041852-1.pdfchemotherapy-181027041852-1.pdf
chemotherapy-181027041852-1.pdf
 
Chemotherapy
ChemotherapyChemotherapy
Chemotherapy
 
ESKAPE Pathogens.pptx
ESKAPE Pathogens.pptxESKAPE Pathogens.pptx
ESKAPE Pathogens.pptx
 
Macrolides
MacrolidesMacrolides
Macrolides
 
Mechanism of development for drug resistance
Mechanism of development for drug resistanceMechanism of development for drug resistance
Mechanism of development for drug resistance
 
Mechanism of antibiotic resistance
Mechanism of antibiotic resistanceMechanism of antibiotic resistance
Mechanism of antibiotic resistance
 
Antibiotics and other chemotherapeutic agents -Antimicrobial spectrum and mod...
Antibiotics and other chemotherapeutic agents -Antimicrobial spectrum and mod...Antibiotics and other chemotherapeutic agents -Antimicrobial spectrum and mod...
Antibiotics and other chemotherapeutic agents -Antimicrobial spectrum and mod...
 

Plus de Dr. Amer Ali Khaleel /HMU (15)

Innate Host Defense Mechanism.ppt
Innate Host Defense Mechanism.pptInnate Host Defense Mechanism.ppt
Innate Host Defense Mechanism.ppt
 
Organs of the Immune system
Organs of the Immune systemOrgans of the Immune system
Organs of the Immune system
 
Cells of the Immune System
Cells of the Immune SystemCells of the Immune System
Cells of the Immune System
 
Introduction to Immunology
Introduction to ImmunologyIntroduction to Immunology
Introduction to Immunology
 
Flow Cytometry (FCM)
Flow Cytometry (FCM) Flow Cytometry (FCM)
Flow Cytometry (FCM)
 
Polyclonal and monoclonal antibody production
Polyclonal and monoclonal antibody productionPolyclonal and monoclonal antibody production
Polyclonal and monoclonal antibody production
 
Infections and cancer
Infections and cancerInfections and cancer
Infections and cancer
 
Whole blood, serum & plasma collections
Whole blood, serum & plasma collectionsWhole blood, serum & plasma collections
Whole blood, serum & plasma collections
 
Electrochemiluminescent (ecl)
Electrochemiluminescent (ecl)Electrochemiluminescent (ecl)
Electrochemiluminescent (ecl)
 
Helicobacter pylori 
Helicobacter pylori Helicobacter pylori 
Helicobacter pylori 
 
Pregnancy test
Pregnancy testPregnancy test
Pregnancy test
 
Brucella test (rose bengal test)
Brucella test (rose bengal test)Brucella test (rose bengal test)
Brucella test (rose bengal test)
 
Widal test
Widal testWidal test
Widal test
 
Immunochromatographic assays
Immunochromatographic assaysImmunochromatographic assays
Immunochromatographic assays
 
Phlebotomy
PhlebotomyPhlebotomy
Phlebotomy
 

Dernier

PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets barmohitRahangdale
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...Sujoy Dasgupta
 
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfHongBiThi1
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyZurück zum Ursprung
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologyDeepakDaniel9
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsMedicoseAcademics
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024EwoutSteyerberg1
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptxNIKITA BHUTE
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationMedicoseAcademics
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Vaikunthan Rajaratnam
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Peter Embi
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.pptRamDBawankar1
 

Dernier (20)

PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets bar
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
 
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturally
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacology
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functions
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
 
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 

Antimicrobial Resistance (AMR)

  • 1. Amer Ali Khaleel M.SC in Medical Immunology Hawler Medical University Antimicrobial Resistance (AMR)
  • 2. 2 Antimicrobial Resistance  Antimicrobial resistance (AMR) is one of the most serious public health threats of the twenty-first century .  Resistance to antimicrobial agents has become a major source of morbidity and mortality worldwide.
  • 3. Nearly 700,000 people around the world die every year due to drug- resistant infections. 3
  • 4. Antimicrobial agents  Antimicrobial agents can be divided into groups based on the mechanism of antimicrobial activity. 1. Agents that inhibit cell wall synthesis. 2. Depolarize the cell membrane. 3. Inhibit protein synthesis. 4. Inhibit nuclei acid synthesis. 5. Inhibit metabolic pathways in bacteria. 4
  • 5. 5 Antimicrobial Resistance  Most pathogenic microorganisms have the capability of developing resistance to at least some antimicrobial agents.
  • 6. Factors contributing to Antibiotic Resistance 1- Environmental Factors. 2- Drug Related Factors. 3- Patient Related Factors. 4- Physician Related Factors. 6
  • 7. 1. Environmental Factors 1. Huge populations and overcrowding 2. Rapid spread – increased travelling 3. Poor sanitation 4. Increases community acquired resistance 5. Ineffective infection control program 6. Increasing national and international travel. 7. Widespread use of antibiotics in animal husbandry and agriculture and as medicated cleansing products. 7
  • 8. 2- Drug Related Factors 1. Fake drugs. 2. Quality of the drug. 3. Soaring use of antibiotics. 4. Over the counter availability of antimicrobials. 5. Irrational fixed dose combination of antimicrobials 6. Counterfeit and substandard drug causing sub-optimal blood concentration 8
  • 9. 3. Patient Related Factors 1. Poor adherence of dosage Regimens 2. Poverty . 3. Lack of sanitation concept. 4. Lack of education. 5. Self-medication. 6. Misconception. 9
  • 10. 4-Physician / Prescriber Related Factors 1. Inappropriate use of available drugs. 2. Increased empiric poly-antimicrobial use. 3. Overuse of antimicrobials. 4. Inadequate dosing. 5. Lack of current knowledge and training. 10
  • 11. So also just remember , there is natural resistances of bacteria against antibiotics , so it is not fault on these four factors. 11
  • 12. 12
  • 13. Bacteriostatic vs. Bacteriocidal  Static antibiotics include: Chloramphenicol, Macrolides, Clindamycin, Sulfa, Trimethoprim, Tetracyclines  Cidal antibiotics include: Aminoglycosides, Beta- lactams, Vancomycin, Quinolones, Rifampin, and Metronidazole. 13
  • 14. ANTIMICROBIAL RESISTANCE Antimicrobial resistance can be of two types, intrin-sic and acquired. 14
  • 15. 15  Intrinsic or natural (always expressed in the species), It is the innate ability of a bacterium to resist a class of antibiotics.  The most common bacterial mechanisms involved in intrinsic resistance are reduced permeability of the outer membrane (LPS) and the natural activity of efflux pumps.
  • 16. 16 b) Acquired resistance whereby a naturally susceptible microorganism acquires ways of not being affected by the drug.  Bacteria acquire any genetic material: transformation, transposition, and conjugation (all termed horizontal gene transfer-HGT), plus, the bacteria may experience mutations to its own chromosomal DNA.
  • 18. Mechanism of Antimicrobial Resistance  Bacteria develop antimicrobial resistance by several mechanisms. 1. Limiting uptake of a drug. (natural) 2. Modification of a drug target. 3. Inactivation of a drug. 4. Active efflux of a drug. 18
  • 19. Mechanism of Antimicrobial Resistance  Because of differences in structure, there is variation in the types of mechanisms used by Gram negative bacteria versus Gram positive bacteria.  Gram negative bacteria make use of all four main mechanisms, whereas Gram positive bacteria less commonly use limiting the uptake of a drug (don't have an LPS outer membrane), and don't have the capacity for certain types of drug efflux mechanisms. 19
  • 21. 1. Limiting uptake of a drug.  There is a natural difference in the ability of bacteria to limit the uptake of antimicrobial agents.  The structure and functions of the LPS layer in G- bacteria provides a barrier to certain types of molecules. 21
  • 22.  Certain bacteria modify their cell membrane porin channels; thereby preventing the antimicrobials from entering into the cell. (genetics)  There are two main ways in which porin changes can limit drug uptake: a decrease in the number of porins present, and mutations that change the selectivity of the porin channel. 22
  • 23.  This strategy has been observed in many Gram- bacteria such as Pseudomonas, Enterobacter and Klebsiella species against drugs such as imipenem, aminoglycosides and quinolones. 23
  • 24.  Gram positive bacteria, Staphylococcus aureus, recently has developed resistance to vancomycin. Of the two mechanisms that S. aureus uses against vancomycin.  S. aureus produce a thickened cell wall which makes it difficult for the drug to enter the cell and Provides an intermediate resistance to vancomycin. These strains are designated as VISA strains. (non-genetic) 24
  • 25. 2. Modification of a drug target.  There are multiple components in the bacterial cell that may be targets of antimicrobial agents and there are just as many targets that may be modified by the bacteria to enable resistance to those drugs. (genetic) 25
  • 26.  One mechanism of resistance to the β-lactam drugs used almost exclusively by G+ bacteria is via alterations in the structure and/or number of PBPs (penicillin-binding proteins).  PBPs are transpeptidases involved in the construction of peptidoglycan in the cell wall. 26
  • 27.  A change in the number (increase in PBPs that have a decrease in drug binding ability, or decrease in PBPs with normal drug binding) of PBPs impacts the amount of drug that can bind to that target. 27
  • 28.  A change in structure (e.g. PBP2a in S. aureus by acquisition of the mecA gene) may decrease the ability of the drug to bind, or totally inhibit drug binding. 28 Antibiotic
  • 29.  The glycopeptides (e.g. vancomycin) also work by inhibiting cell wall synthesis and lipopeptides (e.g. daptomycin) work by depolarizing the cell membrane.  Resistance to vancomycin has become a major issue in the enterococci (VRE—vancomycin-resistant enterococci) and in Staphylococcus aureus (MRSA- Methicillin-resistant Staphylococcus aureus). 29
  • 30.  Resistance is mediated through acquisition of van genes which results in changes in the structure of peptidoglycan precursors that cause a decrease in the binding ability of vancomycin.  Daptomycin requires the presence of calcium for binding. Mutations in genes (e.g. mprF) change the charge of the cell membrane surface to positive, inhibiting the binding of calcium, and therefore, daptomycin. 30
  • 31.  Resistance to drugs that target the ribosomal subunits may occur via ribosomal mutation (aminoglycosides) ,ribosomal subunit methylation most commonly involving erm genes, or ribosomal protection (tetracyclines).  These mechanisms interfere with the ability of the drug to bind to the ribosome. 31
  • 32.  Selective toxicity (antibiotics) , the only affect the bacterium not human, due to affect the specific genes that only bacteria. 32
  • 33.  For drugs that target nucleic acid synthesis (fluoroquinolones), resistance is via modifications in DNA gyrase (G- bacteria e.g. gyrA) or topoisomerase IV (G + bacteria e.g. grlA).  These mutations cause changes in the structure of gyrase and topoisomerase which decrease or eliminate the ability of the drug to bind to these components. 33
  • 34.  There are two main ways in which bacteria inactivate drugs; by 1-Actual degradation of the drug, or by 2-Transfer of a chemical group to the drug. 34 3. Inactivation of a drug.
  • 35.  1-Actual degradation of the drug, or by The β-lactamases are a very large group of drug hydrolyzing enzymes .Another drug that can be inactivated by hydrolyzation is tetracycline, via the tetX gene. 35
  • 36.  2-Transfer of a chemical group to the drug. Drug inactivation by transfer of a chemical group to the drug most commonly uses transfer of acetyl group.  There are a large number of transferases that have been identified. Acetylation is the most diversely used mechanism, and is known to be used against the aminoglycosides. 36
  • 37.  Bacteria possess chromosomally encoded genes for efflux pumps. Some are expressed constitutively, and others are induced or overexpressed (high-level resistance is usually via a mutation that modifies the transport channel) under certain environmental stimuli or when a suitable substrate is present.  The efflux pumps function primarily to rid the bacterial cell of toxic substances, and many of these pumps will transport a large variety of compounds (multi-drug [MDR] efflux pumps). 37 4. Active efflux of a drug.
  • 38.  Most bacteria possess many different types of efflux pumps.  There are five main families of efflux pumps in bacteria classified based on structure and energy source: 1-The ATP-binding cassette (ABC) family, 2-The multidrug and toxic compound extrusion (MATE) family, 3-The small multidrug resistance (SMR) family, 4-The major facilitator superfamily (MFS), and 5-The resistance-nodulation-cell division (RND) family. 38
  • 39.  Efflux pumps found in G + bacteria may confer intrinsic resistance because of being encoded on the chromosome (natural).  There are also G + efflux pumps known to be carried on plasmids (aquarid).  These pumps include members of the MATE and MFS families.  Efflux pumps found in G -bacteria are widely distributed and may come from all five of the families, with the most clinically significant pumps belonging to the RND family. 39
  • 40. 40 Figure: General structure of main efflux pump families.
  • 41. What is the difference between antibiotic and antimicrobial resistance?  Antibiotics are medicines used to prevent and treat bacterial infections. Antibiotic resistance occurs when bacteria change in response to the use of these medicines. Bacteria, not humans, become antibiotic resistant. These bacteria may then infect humans and are harder to treat than non-resistant bacteria.  Antimicrobial resistance is a broader term, encompassing resistance to drugs to treat infections caused by other microbes as well, such as parasites (e.g. malaria), viruses (e.g. HIV) and fungi (e.g. Candida). 41
  • 42. 42
  • 44. References  An overview of the antimicrobial resistance mechanisms of bacteria ,2018, doi: 10.3934/microbiol.2018.3.482.  A Review on Antibiotic Resistance: Alarm Bells are Ringing,2017, doi: 10.7759/cureus.1403  WHO,2018  CDC,2018 44

Notes de l'éditeur

  1. Policy Decision at Higher
  2. Patient Counseling Awareness
  3. • Intrinsic Resistance: It is the innate ability of a bacterium to resist a class of antibiotics The most common bacterial mechanisms involved in intrinsic resistance are reduced permeability of the outer membrane (most specifically the lipopolysaccharide, LPS, in gram negative bacteria) and the natural activity of efflux pumps. • Acquired Resistance: It is the emergence of resistance in bacteria, by acquiring the drug resistant genes either by – (i) mutational or by (ii) transferable drug resistance
  4. • Acquired Resistance: It is the emergence of resistance in bacteria, by acquiring the drug resistant genes either by – (i) mutational or by (ii) transferable drug resistance The acquisition may be temporary or permanent.
  5. 1. Limiting drug uptake
  6. 1. Limiting drug uptake
  7. 1. Limiting drug uptake
  8. gram positive bacteria do not possess an outer membrane, and restricting drug access is not as prevalent. VISA strains= VANCOMYCIN INTERMEDIATE S AURUA
  9. 3. By modification of the antimicrobial target sites within the bacteria: This strategy has been observed in: • MRSA (Methicillin resistant Staphylococcus aureus) • VRE (Vancomycin resistant Enterococci) • Streptomycin resistance in Mycobacterium tuberculosis: Due to modification of ribosomal proteins or 16SrRNA. • Rifampicin resistance in Mycobacterium tuberculosis: Due to mutations in RNA polymerase. • Quinolone resistance (seen in S. aureus and S. pneumoniae): Due to mutations in DNA gyrase enzyme.
  10. Erm=A gene that promotes methylation of ribosomal RNA
  11. Tetracycline resistance protein from transposon. tetanus toxin